American depository receipts of European stocks were trading 0.09% higher at 140.14 on the Bank of New York Mellon Europe ADR Index on Tuesday.
In continental Europe, the gainers were led by cell therapy company TiGenix ( TIG ), and biopharmaceutical company ERYTECH Pharma ( ERYP ), which rose 4.7% and 3.9% respectively. They were followed by online hotel search platform Trivago ( TRVG ), up 3.9%, and 3D printer company Materialise ( MTLS ), up 2.6%.
The decliners in continental Europe were led by biotech company argenx ( ARGX ), and telecommunications operator Telecom Italia (TI), which dropped 3.5% and 2.8% respectively. They were followed by biotech firm Zealand Pharma (ZEAL), and telecommunications firm Telefonica (TEF), which shed 2.5% each.
In the UK and Ireland, the gainers were led by Midatech Pharma (MTP), and gene therapy company Nightstar (NITE), which rose 5.7% and 5.4% respectively. They were followed by biopharmaceutical firm Motif Bio (MTFB), up 3.7%, and biotech firm Shire (SHPG), up 1.7%.
The decliners in the UK and Ireland were led by biopharmaceutical companies Akari Therapeutics (AKTX), and NuCana (NCNA), which fell 8.8% and 2% respectively. They were followed by CRH (CRH), a manufacturer of construction materials, and airline operator Ryanair (RYAAY), which declined 1.5% and 1.3% respectively.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.